11/29/2012 - 3:29pm

The global market for generic drugs will reach more than $125 billion next year, according to a new report by a British market-research firm.

11/29/2012 - 11:28am

The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

11/28/2012 - 1:48pm

The Food and Drug Administration has approved a drug from Perrigo and Cobrek Pharmaceuticals for treating scalp conditions.

11/28/2012 - 1:20pm

Price inflation for the most commonly used branded drugs has been more than six times that of overall inflation for consumer goods since September 2011, according to a new report by pharmacy benefit manager Express Scripts.

11/28/2012 - 12:18pm

Dr. Reddy's Labs has appointed a new CFO and head of its North America business, the generic drug maker said.

11/27/2012 - 1:49pm

Indian generic drug maker Wockhardt received three new drug approvals from the Food and Drug Administration, agency records show.

11/27/2012 - 1:07pm

Ranbaxy Labs has recalled more than three dozen lots of its generic version of a cholesterol-lowering statin drug due to the possible presence of foreign particles, the company said.

11/27/2012 - 11:26am

Automated phone and mail reminders increase the likelihood that patients with new prescriptions for cholesterol-lowering drugs will pick them up from the pharmacy, according to a new study.

11/26/2012 - 5:26pm

When it comes to medication nonadherence, the most oftcited statistic illustrating its effect on the healthcare system is the New England Healthcare Institute's estimate that it costs the healthcare system $290 billion per year. But a new report shows how much drug makers lose as well.